» Articles » PMID: 20629667

Visual Signs and Symptoms of Progressive Supranuclear Palsy

Overview
Journal Clin Exp Optom
Specialty Ophthalmology
Date 2010 Jul 16
PMID 20629667
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive supranuclear palsy is a rare, degenerative brain disorder and the second most common syndrome in which the patient exhibits 'parkinsonism', that is, a variety of symptoms involving problems with movement. General symptoms include difficulties with gait and balance; the patient walking clumsily and often falling backwards. The syndrome can be difficult to diagnose and visual signs and symptoms can help to separate it from closely related movement disorders such as Parkinson's disease, multiple system atrophy, dementia with Lewy bodies and corticobasal degeneration. A combination of the presence of vertical supranuclear gaze palsy, fixation instability, lid retraction, blepharospasm and apraxia of eyelid opening and closing may be useful visual signs in the identification of progressive supranuclear palsy. As primary eye-care practitioners, optometrists should be able to identify the visual problems of patients with this disorder and be expected to work with patients and their carers to manage their visual welfare.

Citing Articles

Clinical Utility of Tectal Plate Measurements on Magnetic Resonance Imaging in Progressive Supranuclear Palsy.

Amrami A, Singh N, Ali F, Pham N, Stephens Y, Josephs K Mov Disord. 2024; 39(8):1402-1407.

PMID: 38586905 PMC: 11341258. DOI: 10.1002/mds.29806.


Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and Sub-haplotypes.

Wang H, Chang T, Dombroski B, Cheng P, Si Y, Tucci A medRxiv. 2024; .

PMID: 38464214 PMC: 10925353. DOI: 10.1101/2024.02.26.24303379.


Genetic and Epigenetic Constructs of Progressive Supranuclear Palsy.

Debnath M, Dey S, Sreenivas N, Pal P, Yadav R Ann Neurosci. 2022; 29(2-3):177-188.

PMID: 36419517 PMC: 9676335. DOI: 10.1177/09727531221089396.


Mass spectrometry-based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways.

Jang Y, Thuraisamy T, Redding-Ochoa J, Pletnikova O, Troncoso J, Rosenthal L Clin Transl Med. 2022; 12(11):e1076.

PMID: 36354133 PMC: 9647849. DOI: 10.1002/ctm2.1076.


Eye tracking identifies biomarkers in α-synucleinopathies versus progressive supranuclear palsy.

Habibi M, Oertel W, White B, Brien D, Coe B, Riek H J Neurol. 2022; 269(9):4920-4938.

PMID: 35501501 PMC: 9363304. DOI: 10.1007/s00415-022-11136-5.